We recently published an article titled These 10 Companies Led Monday’s Downturn. In this article, we are going to take a ...
Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...
B. Riley lowered the firm’s price target on Viking Therapeutics (VKTX) to $96 from $109 and keeps a Buy rating on the shares.
Maxim lowered the firm’s price target on Viking Therapeutics (VKTX) to $70 from $120 and keeps a Buy rating on the shares after the company’s ...
We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at ...
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) is expected to release its earnings data after the market closes on ...
Viking Therapeutics announces its fourth-quarter financial results after Wednesday's closing bell. Here's a look at the ...
On Thursday, Truist Securities reaffirmed its Buy rating and $120.00 price target for Viking Therapeutics (NASDAQ:VKTX) stock. The positive stance comes as competitor ...
Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback